PATENT CLAIM ANALYSIS

Application Number: 16030253
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "044000"]

Abstract:
This invention relates to compounds, compositions, and methods useful for reducing β-catenin target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Claim (Index 20):
A pharmaceutical composition comprising the dsNA of  claim 1  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15064376', '13718525', '14925952', '14300754', '14543257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8805617357615151
- 35 USC 102 Novelty (BERT): 0.7049400920628793
- Combined Prediction Score: 0.8629995713916515
- Mean Citation Score: 747.1398780000003
- Max Citation Score: 795.2667
- Similarity Product: 738.8432611840726

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test